msp2 | msp1 | ||||||
---|---|---|---|---|---|---|---|
Outcome | Child (study ID) | Daya | FC27b | ICb | K1b | MAD20b | RO33b |
Recrudescences | K152 | 0 | - |
599.84
505.26 | - | - | 157.51 |
K152 | 21 | - | 599.76 | - | - | 157.50 | |
K97 | 0 | - | 559.63 | 246.15 | - | - | |
K97 | 21 | - | 559.62 | 246.05 | - | - | |
M107 | 0 | - | 523.93 | - | 220.00 | - | |
M107 | 21 | - | 523.93 | - | 220.00 | - | |
M131 | 0 | - | 487.40 | - | 202.01 | - | |
M131 | 21 | - | 487.33 | - | 202.01 | - | |
M152 | 0 | - | 528.70 | 219.25 | - | - | |
M152 | 21 | - | 528.61 | 219.26 | - | - | |
New infections | K108 | 0 | 336.25 | 515.38 | - | - | 157.53 |
K108 | 42 | 336.25 | - | 246.43 | - | - | |
K149 | 0 | 336.30 | 452.49 | 182.77 | 201.89 | - | |
K149 | 28 | 336.24 | 580.85 | 300.79 | 210.91 | - | |
M161 | 0 | 336.30 | 531.02 |
138.73 146.36 |
210.81 220.07 | - | |
M161 | 21 |
335.75
419.85 | 622.87 |
182.72 210.17 | 192.88 | 157.62 | |
M164 | 0 |
336.30
419.71 |
632.64 620.97 | 228.45 | - | - | |
M164 | 28 | 336.30 | 560.93 |
255.70 264.91 | - | 157.53 | |
M165 | 0 |
335.91 373.27 | 464.33 | 210.07 | 210.81 | 157.61 | |
M165 | 28 |
372.97
419.71 | - | 228.28 | - | - | |
M173 | 0 | 372.85 | 531.85 | 246.31 |
220.0 228.15 | - | |
M173 | 42 | 372.14 |
499.35 564.54 |
201.10 264.10 | 246.88 | - |